Pharma Task Force calls for review of drug price control order
The Pharma Task Force, headed by Pharmaceuticals Secretary, Mr V K Subburaj has recommended a review of the Drug (Prices Control) Order, 2013 as well as rationalisation of the inverted duty structure on Active Pharmaceutical Ingredients (APIs) to be at par with pharma goods, whereby the excise duty is brought down from the current 10 per cent.
June 23, 2015: The report of the Task Force was released by the Union Minister for Chemicals and Fertilisers, Mr Ananth Kumar who stated, "The pharmaceuticals industry will be globally competitive in the next one year. That is my assurance". The Task Force also came up with the recommendations of the creation of a High Level Coordination Committee headed by the Secretary which will review the constraints faced by the industry on a regular basis, constitution of a promotional corporate body and setting up of regulatory cell at institutes like National Institute of Pharmaceutical Education and Research (NIPER).
"The Indian pharma industry will not have to run from pillar to post anymore, they can just approach the Coordination Committee,", Mr Kumar stated.
Other key suggestions of the task force included, having one drug inspector per 50 manufacturing units and one inspector per 200 sales/distribution outlets, funding and infrastructure support, R&D, process support and capacity building.
"These recommendations can help sort out all problems through a single window," added Mr Kumar.
Three new NIPERs would come up in Maharashtra, Chhattisgarh and Rajasthan, whereas the Jan Aushadhi scheme would be driven in a mission mode to establish 3,000 outlets in every district hospital in every state.